Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Ultivue

Ultivue?uq=UG6efJS6
2015 FOUNDED
PRIVATE STATUS
Series B LATEST DEAL TYPE
$20.2M LATEST DEAL AMOUNT
6 INVESTORS
Description

Developer of a reagent-driven technology designed for high-definition biological imaging in situ multiplexing. The company develops proprietary reagents, instruments, and bioinformatics tools for life sciences research and medical diagnostics, enabling researchers and clinicians to provide personalized medicine through better matching of patients with therapeutic options.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Primary Office
  • 763D Concord Avenue
  • Cambridge, MA 02138-1044
  • United States

+1 (617) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Ultivue’s full profile, request a free trial.

Ultivue Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series B) 31-Jan-2018 $20.2M 000.00 0000 Completed Generating Revenue
1. Early Stage VC (Series A) 21-Aug-2015 00.000 00.000 000.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Ultivue Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 000
Series A 0,000,000 00.000000 00 00 00 00 00.000
To view this company’s complete Cap Table, request access »

Ultivue Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
6 Dimensions Capital Venture Capital Minority 000 0000 000000 0
Applied Ventures Corporate Venture Capital Minority 000 0000 000000 0
Sangel Capital Venture Capital Majority 000 0000 000000 0
Yonghua Capital Venture Capital Minority 000 0000 000000 0
ARCH Venture Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Ultivue Executive Team (6)

Name Title Board
Seat
Contact
Info
Michael Natan Ph.D President, Chief Executive Officer & Board Member
Louis Levy Director, Business Development and Corporate
Ralf Jungmann Co-Founder
Philippe Mourere Senior Vice President
David Walt Ph.D Co-Founder, President & Board Member
You’re viewing 5 of 6 executives. Get the full list »

Ultivue Board Members (3)

Name Representing Role Since Contact
Info
David Walt Ph.D Self Co-Founder, President & Board Member 000 0000
Keith Crandell ARCH Venture Partners Board Member 000 0000
Michael Natan Ph.D Ultivue President, Chief Executive Officer & Board Member 000 0000